
Vascular Access Devices Market Report and Forecast 2025-2034
Description
The global vascular access devices market size was valued at USD 4.40 Billion in 2024 , driven by the increasing cases of obesity and diabetes across the globe. The market size is anticipated to grow at a CAGR of 6.50% during the forecast period of 2025-2034 to achieve a value of USD 8.26 Billion by 2034 .
Vascular Access Devices: Introduction
Vascular access devices (VADs) are thin, flexible, tube-like equipment that helps in providing long-term access to blood vessels. VADs are also called PICCs, ports, cannulas, drips, or IVs. Vascular access devices may rescue people with cystic fibrosis who need intravenous (IV) antibiotic treatments regularly, such as during an exacerbation. There are two main categories of vascular access devices: peripherally inserted central catheters (PICC) lines and ports.
Global Vascular Access Devices Market Analysis
The vascular access devices market demand is primarily being driven by the rising development in the market, along with the increasing efforts by the key players. The Teleflex Incorporated, a leading global provider of medical technologies, announced that Premier has awarded them a national agreement for Hemodynamic Monitoring Products and Accessories, a national agreement for Central Venous Access, a Sole Source for AscenDrive Central Venous Access, and a Sole Source for SURPASS Central Venous Access. Teleflex’s accessibility and competitiveness are expected to be influenced positively by this. This endorsement of Teleflex's products through these agreements not only affirms the quality and reliability of their offerings but also makes Teleflex a preferred name in the market, which will directly contribute to the vascular access devices market share.
Both the companies have agreed on some special pricing and terms negotiated by Premier, which will provide added incentives for healthcare providers to choose Teleflex’s solutions, which is expected to potentially influence their purchasing decisions on a broader scale and contribute to Teleflex’s market expansion and the global vascular access devices market growth.
The market demand is also driven by the increased prevalence of chronic diseases such as heart diseases and non-communicable diseases such as depression, hypertension, and obesity among others. The increasing technological advancement of vascular access devices is a major factor driving the market growth.
Global Vascular Access Devices Market Segmentations
Vascular Access Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Device Type Peripherally Inserted
Central Catheters
Percutaneous Non-tunneled Catheters
Other Central Vascular Access Devices Peripheral Catheter
Midline Catheter
Other Peripheral Vascular Access Devices
The market growth is driven by the increased prevalence of non-communicable diseases and chronic diseases. These diseases include cancer, tuberculosis, cardiovascular disease, depression, obesity, diabetes, and hypertension, among other conditions. These medical conditions require vascular access procedures for intravenous antibiotic treatment and extraction of blood samples, among others. Due to the increased number of vascular access procedures, the market is expected to draw attention of key players to invest in manufacturing and development of advanced equipment to assist.
North America has been leading the vascular access devices market demand and is expected to dominate the market during the forecast period as well. According to the data released by the American Cancer Society, more than 1.9 million new cancer cases are expected to occur in the United States in 2023, excluding basal cell and squamous cell skin cancers. Followed by this data, cancer is expected to account for nearly 609,820 deaths in the United States. The data clearly determines that the demand for vascular access devices is expected to increase in the forecast period as a huge population is expected to be diagnosed with cancer, which will result in increased treatment demand for the condition in healthcare facilities, propelling the market growth.
Global Vascular Access Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Vascular Access Devices: Introduction
Vascular access devices (VADs) are thin, flexible, tube-like equipment that helps in providing long-term access to blood vessels. VADs are also called PICCs, ports, cannulas, drips, or IVs. Vascular access devices may rescue people with cystic fibrosis who need intravenous (IV) antibiotic treatments regularly, such as during an exacerbation. There are two main categories of vascular access devices: peripherally inserted central catheters (PICC) lines and ports.
Global Vascular Access Devices Market Analysis
The vascular access devices market demand is primarily being driven by the rising development in the market, along with the increasing efforts by the key players. The Teleflex Incorporated, a leading global provider of medical technologies, announced that Premier has awarded them a national agreement for Hemodynamic Monitoring Products and Accessories, a national agreement for Central Venous Access, a Sole Source for AscenDrive Central Venous Access, and a Sole Source for SURPASS Central Venous Access. Teleflex’s accessibility and competitiveness are expected to be influenced positively by this. This endorsement of Teleflex's products through these agreements not only affirms the quality and reliability of their offerings but also makes Teleflex a preferred name in the market, which will directly contribute to the vascular access devices market share.
Both the companies have agreed on some special pricing and terms negotiated by Premier, which will provide added incentives for healthcare providers to choose Teleflex’s solutions, which is expected to potentially influence their purchasing decisions on a broader scale and contribute to Teleflex’s market expansion and the global vascular access devices market growth.
The market demand is also driven by the increased prevalence of chronic diseases such as heart diseases and non-communicable diseases such as depression, hypertension, and obesity among others. The increasing technological advancement of vascular access devices is a major factor driving the market growth.
Global Vascular Access Devices Market Segmentations
Vascular Access Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Device Type
- Central Vascular Access Devices
- Peripheral Vascular Access Devices
- Accessories
- Intravenous
- Subcutaneous
- Administration of Drugs
- Administration of Fluid and Nutrition
- Diagnostics and Testing
- Other Applications
- Hospitals
- Speciality Clinics
- Home Healthcare
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The market growth is driven by the increased prevalence of non-communicable diseases and chronic diseases. These diseases include cancer, tuberculosis, cardiovascular disease, depression, obesity, diabetes, and hypertension, among other conditions. These medical conditions require vascular access procedures for intravenous antibiotic treatment and extraction of blood samples, among others. Due to the increased number of vascular access procedures, the market is expected to draw attention of key players to invest in manufacturing and development of advanced equipment to assist.
North America has been leading the vascular access devices market demand and is expected to dominate the market during the forecast period as well. According to the data released by the American Cancer Society, more than 1.9 million new cancer cases are expected to occur in the United States in 2023, excluding basal cell and squamous cell skin cancers. Followed by this data, cancer is expected to account for nearly 609,820 deaths in the United States. The data clearly determines that the demand for vascular access devices is expected to increase in the forecast period as a huge population is expected to be diagnosed with cancer, which will result in increased treatment demand for the condition in healthcare facilities, propelling the market growth.
Global Vascular Access Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Becton, Dickinson and Company
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius Medical Care AG & Co.
- NIPRO Medical Corporation
- Medtronic
- AngioDynamics
- Teleflex Incorporated
- Vygon SA
- Terumo Medical Corporation
- Cardinal Health
- Abbott
- Boston Scientific Corporation
- BIOTRONIK, Inc.
- Shanghai Puyi Medical Instruments Co, Ltd
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Vascular Access Devices Market Overview
- 3.1 Global Vascular Access Devices Market Historical Value (2018-2024)
- 3.2 Global Vascular Access Devices Market Forecast Value (2025-2034)
- 4 Global Vascular Access Devices Market Landscape
- 4.1 Global Vascular Access Devices Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Vascular Access Devices Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Application
- 5 Global Vascular Access Devices Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Vascular Access Devices Market Segmentation
- 6.1 Global Vascular Access Devices Market by Device Type
- 6.1.1 Market Overview
- 6.1.2 Central Vascular Access Devices
- 6.1.2.1 Peripherally Inserted
- 6.1.2.2 Central Catheters
- 6.1.2.3 Percutaneous Non-tunneled Catheters
- 6.1.2.4 Other Central Vascular Access Devices
- 6.1.3 Peripheral Vascular Access Devices
- 6.1.3.1 Peripheral Catheter
- 6.1.3.2 Midline Catheter
- 6.1.3.3 Other Peripheral Vascular Access Devices
- 6.1.4 Accessories
- 6.2 Global Vascular Access Devices Market by Mode of Insertion
- 6.2.1 Market Overview
- 6.2.2 Intravenous
- 6.2.3 Subcutaneous
- 6.3 Global Vascular Access Devices Market by Application
- 6.3.1 Market Overview
- 6.3.2 Administration of Drugs
- 6.3.3 Administration of Fluid and Nutrition
- 6.3.4 Diagnostics and Testing
- 6.3.5 Other Applications
- 6.4 Global Vascular Access Devices Market by End User
- 6.4.1 Market Overview
- 6.4.2 Hospitals
- 6.4.3 Speciality Clinics
- 6.4.4 Home Healthcare
- 6.4.5 Others
- 6.5 Global Vascular Access Devices Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Vascular Access Devices Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Vascular Access Devices Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Vascular Access Devices Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Vascular Access Devices Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Vascular Access Devices Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Becton, Dickinson and Company
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Baxter International Inc.
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 B. Braun Melsungen AG
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Fresenius Medical Care AG & Co.
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 NIPRO Medical Corporation
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Medtronic
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 AngioDynamics
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Teleflex Incorporated
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Vygon SA
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Terumo Medical Corporation
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Cardinal Health
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Abbott
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Boston Scientific Corporation
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 BIOTRONIK, Inc.
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Shanghai Puyi Medical Instruments Co, Ltd
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 18 Global Vascular Access Devices Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.